BCM Technologies Inc.

Eleven Greenway Plaza, Suite 2900

Houston, TX 77046

713-795-0105

www.bcmtechnologies.com

Abstract Description

Focuses exclusively on early stage investing in the life sciences.

Management

Dr. Alfred Brown- President; Benjamin Hertzog- Vice President Paul Tufano- CFO

Keywords

invests, seed money, raising capital, capital, venture fund, investment, early-stage

Comment | Printable Version | 1 of 1 | |

network/Financial and Investment/, Venture Fund

Description

BCM Technologies focuses exclusively on early stage investing in the life sciences. The firm typically leads seed and series A rounds and will co-invest in later rounds. BCM Technologies focuses on opportunities with considerable commercialization potential and clear competitive advantage in existing markets or innovative early entrants in growing niche markets.

Customers/Clients

Agennix EnVivo Pharmaceuticals Fairway Medical Technologies Kardia Therapeutics Kryptiq Corporation Medical Metrics MirthaGen Molecular Logix Oncovance Technologies Opexa Therapeutics Progression Therapeutics Prokaryon Technologies Sapphire Therapeutics

2012-02-08-1129 SELECT * FROM `master` WHERE CompanyID='9532' AND `Profile_Type` LIKE 'resource' AND `Approved` LIKE 'YES' ORDER BY `Member_Priority` ASC LIMIT 0 , 30